Michael M Frank

Duke University

$2,330,494

Attributed

$2,330,494

Total exposure

Grants

Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).

Funding over time

peak $231.7K · FY2009–12

$250K$187.5K$125K$62.5K$0

'09

'10

'11

'12

Funding mix

By agency

NIH$2,330,494 · 4

By mechanism

T32$1,040,984 · 2

K12$862,850 · 1

R21$426,660 · 1

Top collaborators

No co-investigators on record.

Most similar at Duke University

Same institution · by research overlap

Catherine Bowes Rickman$11,208,971
Gowthami M Arepally$11,531,413
Kevin O Saunders$14,270,231
Barton F Haynes$531,570,874
Lubica Rauova$2,618,913

Others in their field

Top investigators on “Adjuvant”

Lawrence Corey · Fred Hutchinson Cancer Center$377,142,999
Norman Wolmark · Nsabp Foundation, Inc.$267,141,611
Glenda E Gray · Wits Health Consortium (Pty), Ltd$167,183,168
David Heimbrook · Leidos Biomedical Research, Inc.$151,668,128
Margaret Juliana McElrath · Fred Hutchinson Cancer Center$131,206,481
Peter B. Gilbert · Fred Hutchinson Cancer Center$117,668,001

Research focus

AdjuvantAffectAffinityAids/Hiv ProblemAlternative Complement PathwayAntibodiesAntibody AffinityAntibody FormationAntigen-Antibody ComplexAntigen BindingAntigensAntimicrobialBacteriaBaseB-Cell ActivationBinding (Molecular Function)Binding ProteinsB-LymphocytesCaviaCd4 Positive T LymphocytesCell LineageCell ModelCellsAcquired Immunodeficiency Syndrome